AU2010304915B2 - Staphylococcus aureus Divi1B for use as vaccine - Google Patents

Staphylococcus aureus Divi1B for use as vaccine Download PDF

Info

Publication number
AU2010304915B2
AU2010304915B2 AU2010304915A AU2010304915A AU2010304915B2 AU 2010304915 B2 AU2010304915 B2 AU 2010304915B2 AU 2010304915 A AU2010304915 A AU 2010304915A AU 2010304915 A AU2010304915 A AU 2010304915A AU 2010304915 B2 AU2010304915 B2 AU 2010304915B2
Authority
AU
Australia
Prior art keywords
polypeptide
amino acid
vaccine
sequence
vaccine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010304915A
Other languages
English (en)
Other versions
AU2010304915A1 (en
Inventor
Simon Foster
Jorge Garcia Lara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Absynth Biologics Ltd
Original Assignee
Absynth Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Absynth Biologics Ltd filed Critical Absynth Biologics Ltd
Publication of AU2010304915A1 publication Critical patent/AU2010304915A1/en
Application granted granted Critical
Publication of AU2010304915B2 publication Critical patent/AU2010304915B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2010304915A 2009-10-09 2010-09-13 Staphylococcus aureus Divi1B for use as vaccine Ceased AU2010304915B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0917685.0A GB0917685D0 (en) 2009-10-09 2009-10-09 Antigenic polypeptide
GB0917685.0 2009-10-09
PCT/GB2010/001722 WO2011042681A1 (en) 2009-10-09 2010-09-13 Staphylococcus aureus divi1b for use as vaccine

Publications (2)

Publication Number Publication Date
AU2010304915A1 AU2010304915A1 (en) 2012-03-22
AU2010304915B2 true AU2010304915B2 (en) 2014-06-12

Family

ID=41402763

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010304915A Ceased AU2010304915B2 (en) 2009-10-09 2010-09-13 Staphylococcus aureus Divi1B for use as vaccine

Country Status (8)

Country Link
US (2) US8691242B2 (cg-RX-API-DMAC7.html)
EP (1) EP2485757A1 (cg-RX-API-DMAC7.html)
JP (1) JP5963674B2 (cg-RX-API-DMAC7.html)
CN (1) CN102481353B (cg-RX-API-DMAC7.html)
AU (1) AU2010304915B2 (cg-RX-API-DMAC7.html)
CA (1) CA2775997A1 (cg-RX-API-DMAC7.html)
GB (1) GB0917685D0 (cg-RX-API-DMAC7.html)
WO (1) WO2011042681A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201206366D0 (en) * 2012-04-11 2012-05-23 Absynth Biologics Ltd Bacterial vaccine
GB201417214D0 (en) 2014-09-30 2014-11-12 Absynth Biologics Ltd Vaccine
CN116904356B (zh) * 2022-06-22 2026-06-23 浙江省农业科学院 模仿葡萄球菌hz01菌剂

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854186A2 (en) * 1997-01-02 1998-07-22 Smithkline Beecham Corporation Staphylococcus aureus cell division gene DivIB
WO2002094868A2 (en) * 2001-03-27 2002-11-28 Chiron Srl. Staphylococcus aureus proteins and nucleic acids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022706A (en) * 1997-04-09 2000-02-08 Smithkline Beecham Corporation Div1b
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
PT1551357E (pt) * 2002-09-13 2014-10-10 Novartis Vaccines & Diagnostic Vacina contra os estreptococos do grupo b
GB0409559D0 (en) * 2004-04-29 2004-06-02 Univ Sheffield Polypeptide
GB0505949D0 (en) * 2005-03-23 2005-04-27 Univ Sheffield Polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854186A2 (en) * 1997-01-02 1998-07-22 Smithkline Beecham Corporation Staphylococcus aureus cell division gene DivIB
WO2002094868A2 (en) * 2001-03-27 2002-11-28 Chiron Srl. Staphylococcus aureus proteins and nucleic acids

Also Published As

Publication number Publication date
GB0917685D0 (en) 2009-11-25
EP2485757A1 (en) 2012-08-15
WO2011042681A1 (en) 2011-04-14
AU2010304915A1 (en) 2012-03-22
CN102481353B (zh) 2015-01-14
US20140161835A1 (en) 2014-06-12
CA2775997A1 (en) 2011-04-14
JP5963674B2 (ja) 2016-08-03
JP2013507116A (ja) 2013-03-04
US20120195920A1 (en) 2012-08-02
CN102481353A (zh) 2012-05-30
US8691242B2 (en) 2014-04-08

Similar Documents

Publication Publication Date Title
US8691242B2 (en) Staphylococcus aureus DIV1B for use as vaccine
EP2376111A1 (en) Polypeptides for inducing a protective immune response against staphylococcus aureus
AU2017203173A1 (en) Method For The Production Of Protein Complexes And Vaccine Compositions Comprising The Same
US8124108B2 (en) Polypeptides for inducing a protective immune response against Staphylococcus epidermidis
US9233150B2 (en) Combination vaccine
US20100104591A1 (en) Polypeptides for inducing a protective immune response against staphylococcus epidermidis
US9610341B2 (en) Bacterial vaccine

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired